Since the "dead Pool" made their intentions made clear

New Post Public Reply Private Reply Replies (0) Message Board
HCIT
431
Since the "dead Pool" made their intentions made clear after the infamous letter from the fda, the shares of our stock have come to a virtual halt showing some what of an illiquid scenario where we have been trading in very tight ranges of late.

Is this accumulation from the "dead pool"? IDK but its surely trading in patterns we haven't seen in a very, very long time. Is it them, or is it algo's or is it paid brokers trying very hard to keep the pressure on trading ranges?

Again, IDK but with all that we have going on overseas like Brazil, India and the Philippines trials or non trials or lack of there of, I wonder also why no forward progress is being made or reported. I understand that Brazilian trials have yet to begin, (sometime in June 2021 and I hope the protocol is accepted in short term), it's hard to see anything happening right now.

I know some say, PLEASE, no CC's, no PR's unless something is done but look at us here, we are starving for news updates on where we are right now. I must say, I liked that they PR'd the fact that CYDY is ready to submit or has already announced the possible submitting of the protocol. The company is keeping us in the loop, I like that and treasure it and these reports are in effect, letting EVERYONE know that CYDY is still moving forward. Would those that say no PR's, no CC's rather not know exactly what the company is doing every day? I can't speak for others but I like the fact that CYDY IS keeping us up to date. That, to me, shows that the company wants us to know rather than not to know what's going on as it happens. Who else does this on the OTC? Normally, most companies on the OTCBB are so quiet and don't inform their shareholders of a single solitary thing until maybe weeks after it happens.

So I say, solid, long time investors want to know these things as they happen and on the other side, those that seem to light bash or out right bash management or the company, complain either way and it's so obvious that it just creates havoc throughout all platforms & message boards so the results are just what I said at the very top of this post, tight ranges in our share price and a tiny bit more volume, a quagmire for sure and it keeps on like this probably until the "dead pool" makes their intentions known.

I just want this company to shine with a molecule we all know is something that every other pharma wants because it works so efficiently that they're just out right jealous they didn't come up with this molecule first.

Sorry everyone, I am just so terribly frustrated that CYDY has so many cannons & artillery honed in on them that it's just my anxiety spilling out and it shouldn't be this way with a drug that has what NO OTHER pharmaceutical company has or can come up with to date and for the last couple years.

These attacks will stop. I won't give me shares away and all that is needed is just one freakin, "Yes Cytodyn, we want your drug approved in our country and regardless of what the US fda say's, we see what Vyrologix has done in our trials and at the end of that approval, we get a nice Purchase order.

Now, is that too much to ask for? - GLTA and especially my long term long friends and early investors

HCIT/ahab333

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
https://media.gettyimages.com/photos/the-grea...wdoE_swYM=
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Join Regency Centers for Upcoming Earnings Conference Call

Updated Category News Views 106

Join Regency Centers for the Earnings Call Regency Centers Corporation invites all interested parties to participate in its earnings conference call following the release of its second quarter results. The Company is scheduled to announce its earnings results, providing valuable insights into its operational performance and strategic initiatives. Details of the Earnings...

Continue Reading
Unlocking the Secrets of Affordable Air Travel in 2025

Updated Category News Views 154

Expedia's 2025 Air Hacks Report Reveals Savings Tips Expedia® has unveiled its latest insights in the 2025 Air Hacks Report, revealing strategies to help travelers save significantly on airfares. This report shatters several common myths about air travel, providing travelers with actionable advice to enjoy their journeys without breaking the bank. Understanding the...

Continue Reading
Blackmer Introduces Revolutionary Hydraulic Adapter Kit for Gas Compressors

Updated Category News Views 121

Blackmer's New Hydraulic Adapter Kit Revolutionizes Gas Compression In an exciting development within the compressor technology sector, Blackmer has unveiled its latest innovation: the Hydraulic Adapter Kit. This kit is designed for upgrading the leading LB080 and LB160 Series Reciprocating Gas Compressors, marking a significant advancement in mobile liquid petroleum gas...

Continue Reading
Understanding Shareholder Rights for PRO, IMXI, and TCBX

Updated Category News Views 125

Exploring Shareholder Rights and Options Halper Sadeh LLC, a law firm dedicated to protecting investor rights, is currently investigating several companies for potential breaches of fiduciary duties and violations of federal securities laws. The focus is on the rights of shareholders as specific companies undergo significant mergers and acquisitions. Recent Transactions...

Continue Reading
InMode Secures Court Ruling to Combat Counterfeit Morpheus8 Sales

Updated Category News Views 246

InMode Takes Legal Action Against Counterfeit Sales InMode Ltd. (NASDAQ: INMD), a prominent name in medical technology, has successfully secured a preliminary injunction from the U.S. District Court, aimed at safeguarding its renowned Morpheus8 radiofrequency devices and related accessories from counterfeit sales. This decision marks a significant victory in InMode's...

Continue Reading